On this episode of Stock Movers:
- Bayer said an experimental stroke-prevention drug showed positive results in a late-stage study, a boost for the German company as it seeks to counter sales declines from aging blockbuster medicines. 
- Hensoldt and other European defense shares are on watch over the latest news around Ukraine
- BHP Group has walked away from a fresh takeover approach for Anglo American Plc, ending an unexpected and short-lived attempt by the world’s largest miner to thwart a planned tie-up between its smaller rival and Canada’s Teck Resources Ltd.

On this episode of Stock Movers: - Bayer said an experimental stroke-prevention drug showed positive results in a late-stage study, a boost for the German company as it seeks to counter sales declines from aging blockbuster medicines. - Hensoldt and other European defense shares are on watch over the latest news around Ukraine - BHP Group has walked away from a fresh takeover approach for Anglo American Plc, ending an unexpected and short-lived attempt by the world&rsquo;s largest miner to thwart a planned tie-up between its smaller rival and Canada&rsquo;s Teck Resources Ltd.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

Bayer Result, Hensoldt Falls, Anglo American's Failed Deal

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/4766ad0d-4bad-4f50-b5be-b39f009844e7/transcript

Advertisement